PDGFRAAmplification is Common in Pediatric and Adult High-Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma-Reference-Cited by-同舟云学术

PDGFRAAmplification is Common in Pediatric and Adult High-Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma

Published:2013-03-18 Issue:5 Volume:23 Page:565-573
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathology

Author:

Phillips Joanna J.,Aranda Derick,Ellison David W.¹,Judkins Alexander R.²,Croul Sidney E.³,Brat Daniel J.⁴,Ligon Keith L.⁵,Horbinski Craig⁶,Venneti Sriram⁷,Zadeh Gelareh⁸,Santi Mariarita⁹,Zhou Shengmei²,Appin Christina L.⁴,Sioletic Stefano¹⁰,Sullivan Lisa M.⁹,Martinez-Lage Maria¹¹,Robinson Aaron E.,Yong William H.¹²,Cloughesy Timothy¹³,Lai Albert¹³,Phillips Heidi S.¹⁴,Marshall Roxanne,Mueller Sabine,Haas-Kogan Daphne A.,Molinaro Annette M.,Perry Arie

Affiliation:

1. Department of Pathology; St. Jude Children's Research Hospital; Memphis; TN

2. Department of Pathology; Children's Hospital Los Angeles

3. Department of Lab Medicine and Pathobiology; Toronto Western Hospital; University of Toronto; Toronto; ON; Canada

4. Department of Pathology and Laboratory Medicine; Emory University, Emory University School of Medicine; Atlanta; GA

5. Department of Medical Oncology and Center for Molecular Oncologic Pathology; Dana Farber Cancer Institute; Boston; MA

6. Department of Pathology & Laboratory Medicine; University of Kentucky; Lexington; KY

7. Memorial Sloan-Kettering Cancer Center; New York; NY

8. Division of Neurosurgery; Toronto Western Hospital; University of Toronto; Toronto; ON; Canada

9. Department of Pathology and Laboratory Medicine; The Children's Hospital of Philadelphia; Philadelphia; PA

10. Department of Pathology; Brigham and Women's Hospital and Harvard Medical School; Boston; MA

11. Department of Pathology and Laboratory Medicine; University of Pennsylvania Health System; Philadelphia; PA

12. Department of Pathology and Laboratory Medicine; David Geffen School of Medicine at the University of California Los Angeles; Los Angeles; CA

13. Department of Neurology; David Geffen School of Medicine at the University of California Los Angeles; Los Angeles; CA

14. Department of Drug Metabolism and Pharmacokinetics; Genentech Inc.; San Francisco; CA

Publisher

Wiley

Subject

Neurology (clinical),Pathology and Forensic Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bpa.12043/fullpdf

Reference32 articles.

1. Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas;Alentorn;Neuro-Oncol,2012

2. The t(4;22)(q12;q11) in a typical chronic myeloid leukaemia fuses BCR to PDGFRA;Baxter;Hum Mol Genet,2002

3. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations;Brennan;PLoS ONE,2009

4. CBTRUS 2011 CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004-2007 http://www.cbtrus.org

5. Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas;Elkhaled;Sci Transl Med,2012

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies;Frontiers in Oncology;2024-07-12

2. Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas;Frontiers in Oncology;2024-03-08

3. Adolescents and Young Adults With Cancer: CNS Tumors;Journal of Clinical Oncology;2023-12-08

4. Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma;Acta Neuropathologica Communications;2023-11-27

5. Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma;Applied Biochemistry and Biotechnology;2023-03-28